These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7723917)

  • 1. Correction of amino acid metabolism during rhEPO therapy in hemodialysis patients results from a better oxygen availability.
    Riedel E; Hampl H
    Nephron; 1995; 69(2):196-7. PubMed ID: 7723917
    [No Abstract]   [Full Text] [Related]  

  • 2. Correction of amino acid metabolism by recombinant human erythropoietin therapy in hemodialysis patients.
    Riedel E; Hampl H; Scigalla P; Nündel M; Kessel M
    Kidney Int Suppl; 1989 Nov; 27():S216-21. PubMed ID: 2636662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of changes in amino acid metabolism in pre-dialysis patients treated with erythropoietin.
    Nishikage H; Kosugi T; Danbara A; Yamamoto J; Matsuo S; Hotta N
    Nephron; 2000 Jul; 85(3):277-8. PubMed ID: 10867545
    [No Abstract]   [Full Text] [Related]  

  • 4. CBF and oxygen metabolism in hemodialysis patients: effects of anemia correction with recombinant human EPO.
    Hirakata H; Yao H; Osato S; Ibayashi S; Onoyama K; Otsuka M; Ichiya Y; Kuwabara Y; Masuda Y; Fujishima M
    Am J Physiol; 1992 May; 262(5 Pt 2):F737-43. PubMed ID: 1590418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of iron requirements during treatment of anemia with recombinant human erythropoietin in patients with chronic renal insufficiency under hemodialysis].
    Oliveira C; Boquinhas H; Gaspar A; Adragão T; Boquinhas JM; Júnior EC; Simões J
    Acta Med Port; 1992 Jul; 5(7):351-7. PubMed ID: 1442178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of rhEPO therapy on the protein metabolism of hemodialysis patients with terminal renal insufficiency.
    Fischer C; Scigalla P; Park W; Becker H; Schiller R; Paust H; Broesicke H; Kessel M
    Contrib Nephrol; 1989; 76():250-6. PubMed ID: 2684526
    [No Abstract]   [Full Text] [Related]  

  • 7. Amino acid and alpha-keto acid metabolism depends on oxygen availability in chronic hemodialysis patients.
    Riedel E; Nündel M; Wendel G; Hampl H
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S56-60. PubMed ID: 10746807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study.
    Pascual J; Teruel JL; Moya JL; Liaño F; Jiménez-Mena M; Ortuño J
    Clin Nephrol; 1991 Jun; 35(6):280-7. PubMed ID: 1831414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous vitamin C can improve anemia in erythropoietin-hyporesponsive hemodialysis patients.
    Jacobs C
    Nat Clin Pract Nephrol; 2006 Oct; 2(10):552-3. PubMed ID: 17003830
    [No Abstract]   [Full Text] [Related]  

  • 10. Echocardiographic findings in patients on maintenance hemodialysis substituted with recombinant human erythropoietin.
    Löw I; Grützmacher P; Bergmann M; Schoeppe W
    Clin Nephrol; 1989 Jan; 31(1):26-30. PubMed ID: 2521587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of corticotropin and growth hormone releasing hormones on their respective secretory axes in chronic hemodialysis patients before and after correction of anemia with recombinant human erythropoietin.
    Ramirez G; Bittle PA; Sanders H; Rabb HA; Bercu BB
    J Clin Endocrinol Metab; 1994 Jan; 78(1):63-9. PubMed ID: 8288716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise in hemodialysis patients after treatment with recombinant human erythropoietin.
    Lundin AP; Akerman MJ; Chesler RM; Delano BG; Goldberg N; Stein RA; Friedman EA
    Nephron; 1991; 58(3):315-9. PubMed ID: 1910154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of erythropoietin treatment on 2,3-bisphosphoglycerate and O2-affinity of red blood cells in children with renal anemia.
    Rapoport I; Engelhardt I; Drung I; Holzhütter H; Schmidt G
    Biomed Biochim Acta; 1990; 49(2-3):S280-3. PubMed ID: 2386518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation improves erythropoietin response.
    Pronai W; Riegler-Keil M; Silberbauer K; Stockenhuber F
    Nephron; 1995; 71(4):395-400. PubMed ID: 8587618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin resistance due to vitamin B12 deficiency. Case report and retrospective analysis of B12 levels after erythropoietin treatment.
    Zachee P; Chew SL; Daelemans R; Lins RL
    Am J Nephrol; 1992; 12(3):188-91. PubMed ID: 1415379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
    Díez J; Iglesias P; Sastre J; Méndez J; Selgas R; Gómez-Pan A
    Nephron; 1996; 74(3):548-54. PubMed ID: 8938679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human erythropoietin (rhEPO) treatment potentiates growth hormone (GH) response to growth hormone releasing hormone (GHRH) stimulation in hemodialysis patients.
    Cremagnani L; Cantalamessa L; Orsatti A; Vigna L; Vallino F; Buccianti G
    Clin Nephrol; 1993 May; 39(5):282-6. PubMed ID: 8513607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of recombinant human erythropoietin on hematopoietic progenitors of chronic hemodialysis patients in vitro and in vivo.
    Hino M; Miyazono K; Urabe A; Takaku F
    Int J Cell Cloning; 1989 Jul; 7(4):257-63. PubMed ID: 2768843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of erythropoietin treatment on thyroid dysfunction in hemodialysis patients with renal anemia.
    Tomoda F; Takata M; Izumino K; Oh-hashi S; Ueno H; Iida H
    Nephron; 1994; 66(3):307-11. PubMed ID: 8190183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved physical performance after treatment of renal anemia with recombinant human erythropoietin.
    Braumann KM; Nonnast-Daniel B; Böning D; Böcker A; Frei U
    Nephron; 1991; 58(2):129-34. PubMed ID: 1865966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.